Yifang Li
China Japan Union Hospital
Changchun, China
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
GPER1 as a therapeutic target in MASLD: evidence for steatosis attenuation by agonist G1 in preclinical models.
Journal: Frontiers in pharmacology
Published: December 09, 2025
GPER1/GIPC1-AMPKα signaling alleviates hepatic steatosis via regulating lipid metabolism and fatty acid oxidation-related gene expression: A novel target in MASLD.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 28, 2025
Roles of peroxisome proliferator-activated receptors (PPARs) in pancreatic metabolic diseases.
Journal: Pharmacological research
Published: November 28, 2025
Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning.
Journal: Scientific reports
Published: July 16, 2024
Effects of the Pituitary-targeted Gland Axes on Hepatic Lipid Homeostasis in Endocrine-associated Fatty Liver Disease-A Concept Worth Revisiting.
Journal: Journal of clinical and translational hepatology
Published: September 19, 2023
Should Medical Students Be Overprotected? A Survey from China and Review About the Roles of Medical Student Under the COVID-19.
Journal: Risk management and healthcare policy
Published: December 23, 2022
From Suspicion to Diagnosis: Analysis on the Clinical Characteristics of 37 Cases of IgG4-Related Disease (IgG4-RD) in Northeast China.
Journal: Journal of inflammation research
Published: March 23, 2022
Advocating early identification and diagnosis of IgG4-related disease in various clinical specialties.
Journal: European journal of internal medicine
Published: February 07, 2022
Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review.
Journal: Reviews in endocrine & metabolic disorders
Published: August 07, 2021
Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD).
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: January 30, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026